ES2124012T3 - Derivados glucosidicos de n-acilalquilaminas que ejercen accion neuroprotectora y neurotrofica utiles en trastornos agudos y cronicos del sistema nervioso central relacionados con excitotoxicidad. - Google Patents

Derivados glucosidicos de n-acilalquilaminas que ejercen accion neuroprotectora y neurotrofica utiles en trastornos agudos y cronicos del sistema nervioso central relacionados con excitotoxicidad.

Info

Publication number
ES2124012T3
ES2124012T3 ES95928857T ES95928857T ES2124012T3 ES 2124012 T3 ES2124012 T3 ES 2124012T3 ES 95928857 T ES95928857 T ES 95928857T ES 95928857 T ES95928857 T ES 95928857T ES 2124012 T3 ES2124012 T3 ES 2124012T3
Authority
ES
Spain
Prior art keywords
acute
nervous system
central nervous
system related
neuroprotectoral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95928857T
Other languages
English (en)
Inventor
Valle Francesco Della
Alberta Leon
Gabriele Marcolongo
Valle Federica Della
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LifeGroup SpA
Original Assignee
LifeGroup SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LifeGroup SpA filed Critical LifeGroup SpA
Application granted granted Critical
Publication of ES2124012T3 publication Critical patent/ES2124012T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Psychology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA SIGUIENTE DESCRIPCION CONCIERNE A NUEVOS DERIVADOS GLUCOSIDICOS DE N-ACIL ALQUILAMINAS Y SU USO EN EL TRATAMIENTO DE TRASTORNOS AGUDOS Y CRONICOS DEL SISTEMA CENTRAL NERVIOSO RELACIONADOS CON LA SOBRESTIMULACION DE RECEPTORES DE AMINOACIDOS EXCITADORES.
ES95928857T 1994-03-21 1995-03-20 Derivados glucosidicos de n-acilalquilaminas que ejercen accion neuroprotectora y neurotrofica utiles en trastornos agudos y cronicos del sistema nervioso central relacionados con excitotoxicidad. Expired - Lifetime ES2124012T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI940524A IT1271624B (it) 1994-03-21 1994-03-21 Derivati glucosidici di n-acil alchilamine capaci di esercitare effetto o neuroprotettivo utilizzabili nelle patologie acute e croniche del sistema nervoso centrale correlate ad eccitotossicita'

Publications (1)

Publication Number Publication Date
ES2124012T3 true ES2124012T3 (es) 1999-01-16

Family

ID=11368282

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95928857T Expired - Lifetime ES2124012T3 (es) 1994-03-21 1995-03-20 Derivados glucosidicos de n-acilalquilaminas que ejercen accion neuroprotectora y neurotrofica utiles en trastornos agudos y cronicos del sistema nervioso central relacionados con excitotoxicidad.

Country Status (9)

Country Link
EP (1) EP0751947B1 (es)
JP (1) JP4063864B2 (es)
AT (1) ATE169629T1 (es)
AU (1) AU2110095A (es)
DE (1) DE69504048T2 (es)
DK (1) DK0751947T3 (es)
ES (1) ES2124012T3 (es)
IT (1) IT1271624B (es)
WO (1) WO1995025736A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4070966B2 (ja) * 2001-06-28 2008-04-02 株式会社カネボウ化粧品 新規ガラクトシルセラミド類縁体及び用途
EP1844784B1 (en) * 2006-03-28 2010-04-21 Epitech Group S.r.l. A pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system
KR101116868B1 (ko) * 2008-10-20 2012-02-29 성균관대학교산학협력단 안질환의 예방 또는 치료용 조성물
CN105102466B (zh) * 2012-11-28 2018-07-27 维多利亚林克有限公司 作为bace-1的抑制剂的糖树枝状簇化合物
WO2014084743A1 (en) 2012-11-28 2014-06-05 Callaghan Innovation Research Limited Dendritic core compounds
CN105418698B (zh) * 2015-12-21 2018-04-27 上海市第七人民医院 一种酰胺乙氧基-β-D-葡萄糖苷类化合物及其制备方法和应用
EP3601312A4 (en) * 2017-03-23 2020-12-23 Victoria Link Limited GLYCOMIMETIC COMPOUNDS OF HEPARAN SULPHATE AND THEIR PHARMACEUTICAL AND COSMETIC USES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1260156B (it) * 1992-08-03 1996-03-28 Fidia Spa Derivati dell'acido neuraminico

Also Published As

Publication number Publication date
ATE169629T1 (de) 1998-08-15
WO1995025736A1 (en) 1995-09-28
ITMI940524A0 (it) 1994-03-21
JPH09510469A (ja) 1997-10-21
EP0751947B1 (en) 1998-08-12
IT1271624B (it) 1997-06-04
EP0751947A1 (en) 1997-01-08
ITMI940524A1 (it) 1995-09-21
DK0751947T3 (da) 1999-05-10
DE69504048T2 (de) 1999-04-22
JP4063864B2 (ja) 2008-03-19
AU2110095A (en) 1995-10-09
DE69504048D1 (de) 1998-09-17

Similar Documents

Publication Publication Date Title
ITMI930699A1 (it) Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
TR199901022T2 (xx) Kolostrinin ve kullan�mlar�
PT1010688E (pt) 2-fenil-1-(3,4-di-hidroxi-5-nitrofenil)-1-etanonas substituidas seu uso no tratamento de algumas perturbacoes do sistema nervoso central e periferico e formulacoes do sistema nervoso central e periferico e formulacoes farmaceuticas que as contem
ES2177843T3 (es) Composiciones que contienen l-carnitina o sus derivados y antioxidan tes.
BR9713939A (pt) Processos de preparação de misturas de c5-mononitrortes c4 e de preparação de adiponitrila, misturas de c5-mononitrilas monoolefìnicas, e, corte c4 seletivamente hidrogenado
DE69512819D1 (de) Flüssigkeitsverteiler und Wasserreiniger mit diesem Verteiler
DE59814154D1 (de) Fixationselement
ES2035668T3 (es) Uso de moleculas de adherencia intercelular y sus ligandos de union en el tratamiento del asma.
ES2167401T3 (es) Uso de ascorbil-gamma-linolenato o un ascorbil-dihomo-gamma-linolenato para el tratamiento de asma, cancer, enfermedades cardiovasculares y anti-inflamatorias.
ES2124012T3 (es) Derivados glucosidicos de n-acilalquilaminas que ejercen accion neuroprotectora y neurotrofica utiles en trastornos agudos y cronicos del sistema nervioso central relacionados con excitotoxicidad.
ZA963826B (en) A method of treatment of mania and bipolar disorder
ES2170798T3 (es) Benzopiranos y su uso como agentes terapeuticos.
ES2068388T3 (es) Moleculas de receptor de hormona de la glucoproteina.
ES2038603T3 (es) Empleo de oligopeptidos para el tratamiento de transtornos cerebrales.
ES2060405T3 (es) Derivado de la melatonina que tiene actividad terapeutica en dermatologia.
BG104133A (en) Pharmaceutical suspensiobn containing neurapine semihydrate
DE69631838D1 (de) Verkleidung, miteinander verbundene naturstein-halterungseinheiten und naturstein-halterungseinheit
CA2186245A1 (en) Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity
ES2113765T3 (es) Dimaleato de n,n-dietil-8,8-dipropil-2-azaespiro(4.5)decano-2-propanamina.
ES1027744Y (es) Disposicion perfeccionada para la dteccion y el posicionamiento de signos en maquinas recreativas.
BR9909878A (pt) 10-canfosulfonato de paroxetina para tratamento de distúrbios do sistema nervoso central
ES2141923T3 (es) Uso hipocolesterolemico, antiaterosclerotico e hipotrigliceridemico de derivados aminoacetilmercapto.
ES2156584T3 (es) Androgenos para estimular el sistema nervioso central.
ES1030393Y (es) Dispositivo neumatico para regular la altura de sillines de bicicleta y similares.
Anderson Tracing the Threads: Studies in the Vitality of Jewish Pseudepigrapha

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 751947

Country of ref document: ES